[go: up one dir, main page]

RU95116329A - METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH MYOCARDIAL INFARCTION - Google Patents

METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH MYOCARDIAL INFARCTION

Info

Publication number
RU95116329A
RU95116329A RU95116329/14A RU95116329A RU95116329A RU 95116329 A RU95116329 A RU 95116329A RU 95116329/14 A RU95116329/14 A RU 95116329/14A RU 95116329 A RU95116329 A RU 95116329A RU 95116329 A RU95116329 A RU 95116329A
Authority
RU
Russia
Prior art keywords
patients
prevention
treatment
myocardial infarction
daily
Prior art date
Application number
RU95116329/14A
Other languages
Russian (ru)
Other versions
RU2118182C1 (en
Inventor
Т.Д. Гриднева
Б.И. Лаптев
Е.А. Гончарова
Original Assignee
Томский научно-исследовательский институт курортологии и физиотерапии МЗ и МП РФ
Filing date
Publication date
Application filed by Томский научно-исследовательский институт курортологии и физиотерапии МЗ и МП РФ filed Critical Томский научно-исследовательский институт курортологии и физиотерапии МЗ и МП РФ
Priority to RU95116329A priority Critical patent/RU2118182C1/en
Priority claimed from RU95116329A external-priority patent/RU2118182C1/en
Publication of RU95116329A publication Critical patent/RU95116329A/en
Application granted granted Critical
Publication of RU2118182C1 publication Critical patent/RU2118182C1/en

Links

Claims (1)

Способ профилактики и лечения больных инфарктом миокарда I - IV функциональных классов, включающий активный двигательный режим и электрофорез лекарственного средства, отличающийся тем, что ежедневно в утренние часы больным проводят электрофорез аминазина в количестве 2-3 мл 2,5%-ного раствора на процедуру, а спустя 4-6 дней во вторую половину дня ежедневно больным назначают 4-камерные радоновые ванны, на курс 10-15 процедур.A method for the prevention and treatment of patients with myocardial infarction I-IV functional classes, including active motor mode and electrophoresis of the drug, characterized in that daily in the morning, patients undergo electrophoresis of chlorpromazine in an amount of 2-3 ml of 2.5% solution per procedure, and after 4-6 days in the afternoon, patients are prescribed 4-chamber radon baths daily, for a course of 10-15 procedures.
RU95116329A 1995-09-25 1995-09-25 Method of preventing and treating myocardial infarction RU2118182C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95116329A RU2118182C1 (en) 1995-09-25 1995-09-25 Method of preventing and treating myocardial infarction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95116329A RU2118182C1 (en) 1995-09-25 1995-09-25 Method of preventing and treating myocardial infarction

Publications (2)

Publication Number Publication Date
RU95116329A true RU95116329A (en) 1997-09-10
RU2118182C1 RU2118182C1 (en) 1998-08-27

Family

ID=20172256

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95116329A RU2118182C1 (en) 1995-09-25 1995-09-25 Method of preventing and treating myocardial infarction

Country Status (1)

Country Link
RU (1) RU2118182C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2240838C1 (en) * 2003-07-15 2004-11-27 Государственное образовательное учреждение высшего профессионального образования Санкт-Петербургская государственная медицинская академия им. И.И. Мечникова Method for preventing repeated myocardial infarction in patients with behavioral type a
RU2381795C2 (en) * 2007-06-13 2010-02-20 Денис Сергеевич Кривоносов Method of treating patients with myocardial infarction

Similar Documents

Publication Publication Date Title
BG95935A (en) METHOD AND AGENT FOR ADMINISTERING DEXMEDETOMIDINE DIRECTLY THROUGH THE SKIN
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
FI904092A7 (en) Pharmaceutical preparations for the treatment of severe pain conditions and method for their preparation
UA32636C2 (en) Method for reducing cholesterol content in human blood serum
DE69104777D1 (en) Oral drug forms of biologically active proteins.
SE8501050D0 (en) BIOLOGICALLY ACTIVE FRAGMENTS OF HUMAN ANTIHEMOPHILIC FACTOR AND METHOD FOR PREPARATION THEREOF
EP0570916A3 (en) Human recombinant serum albumin, process for its preparation and pharmaceutical preparations containing it.
DE3787377D1 (en) APPLICATION-ENHANCING AGENTS FOR TRANSDERMAL ADMINISTRATION OF SYSTEMIC AGENTS.
IT1224000B (en) COMPOSITION AND PROCESS FOR HAIR TREATMENT AND CARE
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
FR2632646B1 (en) NITROGEN-CONTAINING CARBOXYMETHYLCELLULOSE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN COSMETIC PREPARATIONS
FR2735132B1 (en) MODIFIED POLYPEPTIDE DRUG, COMPOSITION AND ELECTROTRANSPORT ADMINISTRATION DEVICE CONTAINING SAME
PL326499A1 (en) Transcutateous therapeutic system (tts) for administration of active substances used in treating narcotic dependence or drug addiction
BG44709A3 (en) METHOD FOR PREPARATION OF 9-CHLORO-1,5-BENZOTHIAZEPINE DERIVATIVES
RU95116329A (en) METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH MYOCARDIAL INFARCTION
DK325289D0 (en) STRONTIUM SALT, METHOD OF PREPARING IT, AND PHARMACEUTICAL AGENTS CONTAINING SALT
RU94011321A (en) METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASES
ATA77095A (en) STABLE PREPARATION FOR THE TREATMENT OF BLOOD COAGNING DISORDERS, CONTAINING AN ACTIVE CLOTHING SUBSTANCE
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
FI911269A7 (en) Method and composition for achieving increased concentration of active agents on the skin by iontophoresis
DE68905076D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds.
ATE295731T1 (en) OLNZAPINE FOR THE TREATMENT OF DRUG ABUSE
DE59813114D1 (en) BK-RiV preparations for the treatment of proliferative cell recruitment
IT8763326V0 (en) MEDICAL PRESIDIUM FOR ELECTROMAGNETOTHERAPY.
RU96110047A (en) METHOD FOR PREVENTING ENDOMETRITIS AFTER KESAREV SECTION